Literature DB >> 25639621

Enhancement and induction of HIV-1 infection through an assembled peptide derived from the CD4 binding site of gp120.

Andrea Groß1, Katja Rödel, Barbara Kneidl, Norbert Donhauser, Marek Mössl, Edina Lump, Jan Münch, Barbara Schmidt, Jutta Eichler.   

Abstract

Contact between the human immunodeficiency virus (HIV-1) and its target cell is initiated by the interaction of viral gp120 with cellular CD4. An assembled peptide (CD4bs-M) that presents the CD4 binding site of gp120 was previously shown to inhibit the gp120-CD4 interaction. Here, we demonstrate that CD4bs-M selectively enhances infection of cells with HIV-1, whereas infection with herpes simplex virus remains largely unaffected. The effects of CD4bs-M variants containing D-amino acids, or prolines at selected positions, point to the importance of side chain orientation and spatial orientation of this fragment. Furthermore, CD4bs-M was shown to assemble into amyloid-like fibrils that capture HIV-1 particles, which likely contributes to the infection-enhancing effect. Beyond infection enhancement, CD4bs-M enabled HIV-1 infection of CD4-negative cells, suggesting that binding of the peptide to gp120 facilitates interaction of gp120 with coreceptors, which might in turn enhance HIV-1 entry.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  HIV-1; fibrils; gp120; infection enhancement; peptides

Mesh:

Substances:

Year:  2015        PMID: 25639621     DOI: 10.1002/cbic.201402545

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  8 in total

1.  High-resolution crystal structures of two prototypical β- and γ-herpesviral nuclear egress complexes unravel the determinants of subfamily specificity.

Authors:  Yves A Muller; Sigrun Häge; Sewar Alkhashrom; Tobias Höllriegl; Sebastian Weigert; Simon Dolles; Kerstin Hof; Sascha A Walzer; Claudia Egerer-Sieber; Marcus Conrad; Stephanie Holst; Josephine Lösing; Eric Sonntag; Heinrich Sticht; Jutta Eichler; Manfred Marschall
Journal:  J Biol Chem       Date:  2020-01-24       Impact factor: 5.157

Review 2.  The diversity and utility of amyloid fibrils formed by short amyloidogenic peptides.

Authors:  Zahraa S Al-Garawi; Kyle L Morris; Karen E Marshall; Jutta Eichler; Louise C Serpell
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

3.  A Degraded Fragment of HIV-1 Gp120 in Rat Hepatocytes Forms Fibrils and Enhances HIV-1 Infection.

Authors:  Jinquan Chen; Ruxia Ren; Fei Yu; Chunyan Wang; Xuanxuan Zhang; Wenjuan Li; Suiyi Tan; Shibo Jiang; Shuwen Liu; Lin Li
Journal:  Biophys J       Date:  2017-10-03       Impact factor: 4.033

4.  Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains.

Authors:  Judith Lind; Steffen Backert; Rebecca Hoffmann; Jutta Eichler; Yoshio Yamaoka; Guillermo I Perez-Perez; Javier Torres; Heinrich Sticht; Nicole Tegtmeyer
Journal:  BMC Microbiol       Date:  2016-09-02       Impact factor: 3.605

Review 5.  The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses.

Authors:  Oliver Ringel; Vincent Vieillard; Patrice Debré; Jutta Eichler; Hildegard Büning; Ursula Dietrich
Journal:  Viruses       Date:  2018-04-15       Impact factor: 5.048

Review 6.  Nuclear Egress Complexes of HCMV and Other Herpesviruses: Solving the Puzzle of Sequence Coevolution, Conserved Structures and Subfamily-Spanning Binding Properties.

Authors:  Manfred Marschall; Sigrun Häge; Marcus Conrad; Sewar Alkhashrom; Jintawee Kicuntod; Johannes Schweininger; Mark Kriegel; Josephine Lösing; Julia Tillmanns; Frank Neipel; Jutta Eichler; Yves A Muller; Heinrich Sticht
Journal:  Viruses       Date:  2020-06-24       Impact factor: 5.048

Review 7.  Synthetic Peptides as Protein Mimics.

Authors:  Andrea Groß; Chie Hashimoto; Heinrich Sticht; Jutta Eichler
Journal:  Front Bioeng Biotechnol       Date:  2016-01-19

8.  Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects.

Authors:  Angela Tomasovic; Theresa Brand; Constanze Schanbacher; Sofia Kramer; Martin W Hümmert; Patricio Godoy; Wolfgang Schmidt-Heck; Peter Nordbeck; Jonas Ludwig; Susanne Homann; Armin Wiegering; Timur Shaykhutdinov; Christoph Kratz; Ruth Knüchel; Hans-Konrad Müller-Hermelink; Andreas Rosenwald; Norbert Frey; Jutta Eichler; Dobromir Dobrev; Ali El-Armouche; Jan G Hengstler; Oliver J Müller; Karsten Hinrichs; Friederike Cuello; Alma Zernecke; Kristina Lorenz
Journal:  Nat Commun       Date:  2020-04-07       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.